Why invest in CME?
An investment in CME (Continuing Medical Education) brings numerous benefits to your organisation. It’s important for fulfilling your corporate and social responsibilities. It also raises your credibility, standing and profile in the therapy area.
And consider the areas of clinical practice in your field which, if improved, would benefit patients. It might be better diagnosis, closer adherence to guidelines, increased provision of counselling or improved side effect management to avoid adherence problems or dropout.
At present, you can’t focus your CME content on these topics (due to the potential for inappropriate influence). You may genuinely believe that better treatment – across the whole armamentarium – will benefit all stakeholders. If any objective look at the field would identify the same issues, then CME is the best investment you can make to bring about these improvements in practice.
CME vs unaccredited education
Unaccredited education allows you the freedom to focus heavily on pharmaceutical aspects of treatment and your own product. It also gives you full control of the selection of your chair, faculty, speakers and content, so you can be sure your key messages are reflected throughout.
However, in circumstances where you hope that your education will bring about wider improvements in the management of patients’ health, unaccredited education has some drawbacks.